Microbiota, Mucus, and Modulators: Cystic Fibrosis Infection Pathogenesis in the Cystic Fibrosis Transmembrane Conductance Regulator Modulator Era - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Role of Microbiota, Mucus, and Therapeutic Modulators in the Pathogenesis of Infections in Cystic Fibrosis During the Era of CFTR Modulator Treatments

  • By

  • Christina S Thornton

  • Drake C Bouzek

  • Lindsay J Caverly

  • December 17, 2025

Share

  • 1

    Cystic fibrosis (CF) is caused by mutations in the CFTR gene, leading to impaired ion transport and chronic airway infections.

  • 2

    CF airway infections are polymicrobial, dominated by pathogens like Pseudomonas aeruginosa and Staphylococcus aureus, causing lung damage.

  • 3

    CFTR modulators improve airway hydration and mucociliary clearance but do not eliminate chronic infections in most patients.

  • 4

    Chronic infections in CF are associated with accelerated lung function decline and increased mortality risk.

  • 5

    Diverse bacterial communities in CF airways decline in diversity over time, with traditional pathogens dominating as disease progresses.

Original Source(s)

Related Content